Comparative field evaluation of a next-generation CPD MLV PRRS vaccine versus a traditional MLV in a farm with concurrent PRRSV1 and PRRSV2 circulation
Collaboration in more than 46 countries.
You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.